1887

Abstract

The growth kinetics of wild-type and mutant viruses of human immunodeficiency virus type 1 were comparatively analysed in several human CD4 cell lines. Delayed replication of mutant virus was observed in all cell lines examined. To determine the stage in the virus replication cycle that is affected by Nef, a single-round replication assay was performed. Initially, the expression of marker genes in transfected cells was examined in order to study the role of Nef in the late phase of infection. The results obtained indicated that Nef is dispensable during the transcription to virion pro duction stage. Next, the effect of Nef on the early phase was investigated with a single-round infection. It was demonstrated that Nef is required in the early phase of the virus replication cycle, from virion adsorption to integration. Finally, the infectivity of virus stocks prepared from four cell lines was determined. The relative infectivity of the mutant from the four cell lines differed. Taken together, we conclude that Nef acts via modulation of viral particles to enhance virus infectivity in a cell- dependent manner.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-79-10-2447
1998-10-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/79/10/9780050.html?itemId=/content/journal/jgv/10.1099/0022-1317-79-10-2447&mimeType=html&fmt=ahah

References

  1. Adachi A., Gendelman H. E., Koenig S., Folks T., Willey R., Rabson A., Martin M. A. 1986; Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone. Journal of Virology 59:284–291
    [Google Scholar]
  2. Adachi A., Ono N., Sakai H., Ogawa K., Shibata R., Kiyomasu T., Masuike H., Ueda S. 1991; Generation and characterization of the human immunodeficiency virus type 1 mutants. Archives of Virology 117:45–58
    [Google Scholar]
  3. Ahmad N., Venkatesan S. 1988; Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. Science 241:1481–1485
    [Google Scholar]
  4. Aiken C., Trono D. 1995; Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. Journal of Virology 69:5048–5056
    [Google Scholar]
  5. Chowers M. Y., Spina C. A., Kwoh T. J., Fitch N. J. S., Richman D. D., Guatelli J. C. 1994; Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. Journal of Virology 68:2906–2914
    [Google Scholar]
  6. Chowers M. Y., Pandori M. W., Spina C. A., Richman D. D., Guatelli J. C. 1995; The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation. Virology 212:451–457
    [Google Scholar]
  7. de Ronde A., Klaver B., Keulen W., Smit L., Goudsmit J. 1992; Natural HIV-1 Nef accelerates virus replication in primary human lymphocytes. Virology 188:391–395
    [Google Scholar]
  8. Folks T., Benn S., Rabson A., Theodore T., Hoggan M. D., Martin M., Lightfoote M., Sell K. 1985; Characterization of a continuous T- cell line susceptible to the cytopathic effects of the acquired immune deficiency syndrome (AIDS)-associated retrovirus. Proceedings of the National Academy of Sciences, USA 82:4539–4543
    [Google Scholar]
  9. Gorman C. M., Moffat L. F., Howard B. H. 1982; Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Molecular and Cellular Biology 2:1044–1051
    [Google Scholar]
  10. Gottlinger H. G., Dorfman T., Cohen E. A., Haseltine W. A. 1993; Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proceedings of the National Academy of Sciences, USA 90:7381–7385
    [Google Scholar]
  11. Graham F. L., Van der Eb A. J. 1973; A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456–467
    [Google Scholar]
  12. Hammes S. R., Dixon E. P., Malim M. H., Cullen B. R., Greene W. C. 1989; Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. Proceedings of the National Academy of Sciences, USA 86:9549–9553
    [Google Scholar]
  13. Helseth E., Kowalski M., Gabuzda D., Olshevsky U., Haseltine W., Sodroski J. 1989; Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. Journal of Virology 64:2416–2420
    [Google Scholar]
  14. Jamieson B. D., Aldrovandi G. M., Planelles V., Jowett J. B. M., Gao L., Bloch L. M., Chen I. S. M., Zack J. A. 1994; Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. Journal of Virology 68:3478–3485
    [Google Scholar]
  15. Kestler H. W. III Ringler D. J., Mori K., Panicali D. L., Sehgal P. K., Daniel M. D., Desrosiers R. C. 1991; Importance ofthe nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651–662
    [Google Scholar]
  16. Kim S., Ikeuchi K., Byrn R., Groopman J., Baltimore D. 1989; Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, USA 86:9544–9548
    [Google Scholar]
  17. Kimpton J., Emerman M. 1992; Detection of replication-competent and pseudotype human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated-galactosidase gene. Journal of Virology 66:2232–2239
    [Google Scholar]
  18. Klimkait T., Strebel K., Hoggan M. D., Martin M. A., Orenstein J. M. 1990; The human immunodedeficiency virus type 1-specific protein Vpu is required for efficient virus maturation and release. Journal of Virology 64:621–629
    [Google Scholar]
  19. Miller M. D., Warmerdam M. T., Gaston I., Greene W. C., Feinberg M. B. 1994; The human immunodeficiency virus type 1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. Journal of Experimental Medicine 179:101–113
    [Google Scholar]
  20. Miller M. D., Warmerdam M. T., Page K. A., Feinberg M. B., Greene W. C. 1995; Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry. Journal of Virology 69:579–584
    [Google Scholar]
  21. Niederman T. M. J., Thielan B. J., Ratner L. 1989; Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. Proceedings of the National Academy of Sciences, USA 86:1128–1132
    [Google Scholar]
  22. Popovic M., Sarngadharan M. G., Read E., Gallo R. C. 1988; Detection, isolation and continuous production of cytopathic retroviruses from patients with AIDS and pre-AIDS. Science 224:497–500
    [Google Scholar]
  23. Sakai H., Siomi H., Shida H., Shibata R., Kiyomasu T., Adachi A. 1990; Functional comparison of transactivation by human retrovirus rev and rex genes. Journal of Virology 64:5833–5839
    [Google Scholar]
  24. Sakai H., Tokunaga K., Kawamura M., Adachi A. 1995; Function of human immunodeficiency virus type 1 Vpu protein in various cell types. Journal of General Virology 76:2717–2722
    [Google Scholar]
  25. Salter R. D., Howell D. N., Cresswell P. 1985; Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immuno- genetics 21:235–246
    [Google Scholar]
  26. Schwartz O., Marechal V., Danos O., Heard J.-M. 1995; Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cells. Journal of Virology 69:4053–4059
    [Google Scholar]
  27. Shibata R., Kawamura M., Sakai H., Hayami M., Ishimoto A., Adachi A. 1991; Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. Journal of Virology 65:3514–3520
    [Google Scholar]
  28. Shibata R., Sakai H., Kawamura M., Tokunaga K., Adachi A. 1995; Early replication block of human immunodeficiency virus type 1 in monkey cells. Journal of General Virology 76:2723–2730
    [Google Scholar]
  29. Spina C. A., Kwoh T. J., Chowers M. Y., Guatelli J. C., Richman D. D. 1994; The importance of nef in the induction of human immuno-deficiency virus type 1 replication from primary quiescent CD4 lymphocytes. Journal of Experimental Medicine 179:115–123
    [Google Scholar]
  30. Takai H., Ohmori H. 1990; DNA transfection of mouse lymphoid cells by the combination of DEAE-dextran-mediated DNA uptake and osmotic shock procedure. Biochimca et Biophysica Acta 1048:105–109
    [Google Scholar]
  31. Terwilliger E. F., Sodroski J. G., Rosen C., Haseltine W. A. 1986; Effects of mutations within the 3ʹ orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity. Journal of Virology 60:754–760
    [Google Scholar]
  32. Terwilliger E. F., Langhoff E., Gabuzda D., Azopoulos E., Haseltine W. A. 1991; Allelic variation in the effects of the nefgene on replication of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, USA 88:10971–10975
    [Google Scholar]
  33. Wigler M., Pellecer A., Silverstein S., Axel R., Urlaub G., Chasm L. 1979; DNA-mediated transfer of the adenine phosphoribosyltrans- ferase locus into mammalian cells. Proceedings of the National Academy of Sciences, USA 76:1372–1376
    [Google Scholar]
  34. Willey R. L., Smith D. H., Lasky L. A., Theodore T. S., Earl P. L., Moss B., Capon D. J., Martin M. A. 1988; In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is for critical for infectivity. Journal of Virology 62:139–147
    [Google Scholar]
  35. Zazopoulos E., Haseltine W. A. 1992; Mutational analysis of the human immunodeficiency virus type 1 Eli Nef function. Proceedings of the National Academy of Sciences, USA 89:6634–6638
    [Google Scholar]
  36. Zazopoulos E., Haseltine W. A. 1993; Effect of nef alleles on replication of human immunodeficiency virus type 1. Virology 194:20–27
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-79-10-2447
Loading
/content/journal/jgv/10.1099/0022-1317-79-10-2447
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error